Your session is about to expire
← Back to Search
Dietary Supplement
Yeast Fermentate (EpiCor) for Immune Surveillance
N/A
Waitlist Available
Led By Gitte Jensen, PhD
Research Sponsored by Cargill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1, 2, and 3 hours
Awards & highlights
Study Summary
This trial tests the effects of a nutraceutical on 30 healthy adults, to see if it can improve their immune system.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 1, 2, and 3 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1, 2, and 3 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Immune Surveillance
Secondary outcome measures
Immune Communication
Other outcome measures
Immune Responsiveness
Trial Design
2Treatment groups
Experimental Treatment
Group I: Placebo intervention first and Active intervention one week laterExperimental Treatment1 Intervention
Participants will be consuming a placebo on a clinic day at least one week prior to a clinic day where they will consume the active intervention.
Group II: Active intervention first and Placebo intervention one week laterExperimental Treatment1 Intervention
Participants will be consuming active intervention on a clinic day at least 1 week prior to a clinic day where they will consume the placebo.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yeast Fermentate (EpiCor)
2023
N/A
~30
Find a Location
Who is running the clinical trial?
Natural Immune Systems IncOTHER
18 Previous Clinical Trials
457 Total Patients Enrolled
2 Trials studying Immune Surveillance
48 Patients Enrolled for Immune Surveillance
CargillLead Sponsor
27 Previous Clinical Trials
3,201 Total Patients Enrolled
Gitte Jensen, PhDPrincipal InvestigatorNIS Labs
4 Previous Clinical Trials
96 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are going through very difficult and stressful situations that might make it hard for you to follow the study's instructions.You are currently undergoing intense athletic training, like training for a marathon.You are regularly taking medications for inflammation every day.You have known allergies to any of the ingredients in the test product or placebo, especially if they are related to food.You don't want to take the required supplements consistently throughout the study.You feel very nervous or anxious when getting blood drawn.You are currently taking medicines for depression or anxiety.Any adult, regardless of gender, who is in good health.
Research Study Groups:
This trial has the following groups:- Group 1: Active intervention first and Placebo intervention one week later
- Group 2: Placebo intervention first and Active intervention one week later
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger